pirotinib
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2015 (NCT02442414)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
ERBB4 inhibitor
ERBB2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- kbp-5209
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02442414 | Phase 1 | Apr 1, 2015 | Covance, Sihuan Pharmaceutical Holdings Group Ltd., XuanZhu Pharma Co., Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Covance | For profit | 1 | 0 | 1 | 2015 |
| Sihuan Pharmaceutical Holdings Group Ltd. | For profit | 1 | 1 | 1 | 2015 |
| XuanZhu Pharma Co., Ltd. | For profit | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1